Shire PLC (LON:SHP) has earned a consensus recommendation of “Buy” from the nineteen ratings firms that are currently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is GBX 5,845.60 ($75.50).
Several equities analysts have issued reports on SHP shares. Deutsche Bank AG decreased their price objective on shares of Shire PLC from GBX 6,100 ($78.78) to GBX 6,000 ($77.49) and set a “buy” rating for the company in a research note on Tuesday, June 13th. Jefferies Group LLC reduced their target price on shares of Shire PLC from GBX 6,400 ($82.66) to GBX 5,600 ($72.32) and set a “buy” rating for the company in a report on Friday, June 9th. Liberum Capital reaffirmed a “buy” rating and issued a GBX 5,500 ($71.03) target price on shares of Shire PLC in a report on Friday, May 26th. Citigroup Inc. reaffirmed a “buy” rating and issued a GBX 6,500 ($83.95) target price on shares of Shire PLC in a report on Wednesday, May 17th. Finally, Berenberg Bank reduced their target price on shares of Shire PLC from GBX 6,100 ($78.78) to GBX 6,000 ($77.49) and set a “buy” rating for the company in a report on Thursday, June 8th.
In related news, insider Flemming Ornskov purchased 8,400 shares of the business’s stock in a transaction on Tuesday, August 22nd. The shares were bought at an average price of GBX 3,665 ($47.33) per share, with a total value of £307,860 ($397,597.83). Also, insider Dominic Blakemore purchased 152 shares of the business’s stock in a transaction on Friday, June 30th. The shares were bought at an average cost of GBX 4,255 ($54.95) per share, for a total transaction of £6,467.60 ($8,352.83).
COPYRIGHT VIOLATION NOTICE: “Shire PLC (SHP) Receives Average Recommendation of “Buy” from Analysts” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/2888719/shire-plc-shp-receives-average-recommendation-of-buy-from-analysts.html.
Shares of Shire PLC (LON SHP) traded down 0.58% during trading on Wednesday, reaching GBX 4051.00. The company had a trading volume of 874,276 shares. Shire PLC has a 1-year low of GBX 3,603.50 and a 1-year high of GBX 5,377.00. The firm has a 50-day moving average of GBX 3,953.15 and a 200 day moving average of GBX 4,408.47. The firm’s market capitalization is GBX 36.72 billion.
The company also recently announced a dividend, which will be paid on Friday, October 20th. Investors of record on Thursday, September 7th will be given a dividend of GBX 3.85 ($0.05) per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a yield of 0.1%.
Shire PLC Company Profile
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.